Philip Stewart Low

West Lafayette, IN, United States of America

Philip Stewart Low

Average Co-Inventor Count = 2.6

ph-index = 18

Forward Citations = 1,540(Granted Patents)

Forward Citations (Not Self Cited) = 1,001(Sep 21, 2024)

DiyaCoin DiyaCoin 3.72 

Inventors with similar research interests:


Location History:

  • Glenview, IL (US) (2012)
  • West Lafayetter, IN (US) (2014)
  • West Lafayette, IN (US) (1992 - 2024)


Years Active: 1992-2025

where 'Filed Patents' based on already Granted Patents

102 patents (USPTO):
5 patents (CIPO):

Title: **The Innovative Journey of Philip Stewart Low**

Introduction

Philip Stewart Low, based in West Lafayette, IN (US), is a distinguished inventor with an impressive portfolio of around 100 patents. Renowned for his work in drug delivery systems, Low's advancements have greatly contributed to the field of cell therapy and fracture repair, showcasing his significant role in the intersection of science and innovation.

Latest Patents

Among his latest groundbreaking patents is a platform titled "Targeted Ligand-Payload Based Drug Delivery for Cell Therapy." This innovative drug delivery system allows for a flexible fine-tuning of cell therapies by using an engineered fusion protein that is coupled with a high-affinity ligand. This ligand carries a payload of drugs that can be internalized by transplanted cells, thus enabling researchers to observe or manage the effects of transplanted cell therapy more effectively.

Another remarkable patent is "Targeting Anabolic Drugs for Accelerated Fracture Repair." This invention pertains to the targeted delivery of growth factors, vasoactive peptides, and other anabolic peptide drugs to bone fractures, facilitating accelerated healing. This targeted approach emphasizes Low's commitment to advancing therapeutic methods to enhance patient outcomes.

Career Highlights

Philip Stewart Low has made notable contributions while working with various esteemed organizations. He has been part of the Purdue Research Foundation, where he likely engaged in significant research and technological development. Additionally, his tenure at Endocyte, Inc. highlights his involvement with a firm focused on developing advanced therapies, particularly in the realm of personalized medicine.

Collaborations

Throughout his innovative career, Low has collaborated with distinguished colleagues such as Sumith A Kularatne and Christopher Paul Leamon. These partnerships have not only contributed to the success of various projects but have also fostered an environment of shared knowledge and breakthrough ideas.

Conclusion

In conclusion, Philip Stewart Low's extensive patent portfolio and collaborative efforts underscore his pivotal role as an inventor in the fields of drug delivery and therapeutic innovation. His work continues to inspire and lead advancements that may significantly improve medical treatments, demonstrating the importance of creativity and technology in enhancing human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…